POZEN (POZN) and Teva Pharma (TEVA) Settle Patent Infringement Lawsuit Regarding Generic Version of Treximet
Tweet Send to a Friend
POZEN Inc. (NASDAQ: POZN), today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
